CAMSAP1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.653200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.259800E-01
Normal-vs-Stage2
5.430200E-01
Normal-vs-Stage3
6.601600E-01
Normal-vs-Stage4
2.892800E-01
Stage1-vs-Stage2
8.705400E-01
Stage1-vs-Stage3
9.583800E-02
Stage1-vs-Stage4
3.354600E-01
Stage2-vs-Stage3
2.192200E-01
Stage2-vs-Stage4
2.242800E-01
Stage3-vs-Stage4
9.910300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.964200E-01
Normal-vs-AfricanAmerican
1.848770E-01
Normal-vs-Asian
9.658600E-01
Caucasian-vs-AfricanAmerican
1.372400E-01
Caucasian-vs-Asian
3.517200E-01
AfricanAmerican-vs-Asian
3.491800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.850600E-01
Normal-vs-Female
5.319600E-01
Male-vs-Female
8.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.450400E-01
Normal-vs-Age(41-60Yrs)
3.213200E-01
Normal-vs-Age(61-80Yrs)
6.854200E-01
Normal-vs-Age(81-100Yrs)
9.900200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.088600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.413400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.831800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.375900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.104500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.899170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.366000E-01
Normal-vs-Daily Drinker
9.726000E-01
Normal-vs-Weekly Drinker
5.415600E-01
Normal-vs-Occasional Drinker
4.479600E-01
Normal-vs-Social Drinker
4.583600E-01
Non Drinker-vs-Daily Drinker
9.357200E-01
Non Drinker-vs-Weekly Drinker
2.059600E-01
Non Drinker-vs-Occasional Drinker
9.759700E-02
Non Drinker-vs-Social Drinker
1.218780E-01
Daily Drinker-vs-Weekly Drinker
2.517600E-01
Daily Drinker-vs-Occasional Drinker
8.895800E-02
Daily Drinker-vs-Social Drinker
1.224200E-01
Weekly Drinker-vs-Occasional Drinker
5.479600E-01
Weekly Drinker-vs-Social Drinker
3.896600E-01
Occasional Drinker-vs-Social Drinker
6.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.821210E-01
Normal-vs-Grade 2
3.459800E-02
Normal-vs-Grade 3
7.359500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.472150E-01
Grade 1-vs-Grade 3
6.039900E-02
Grade 1-vs-Grade 4
1.821210E-01
Grade 2-vs-Grade 3
2.526800E-01
Grade 2-vs-Grade 4
3.459800E-02
Grade 3-vs-Grade 4
7.359500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.793600E-01
Normal-vs-NonDiabetic
5.904000E-01
Diabetic-vs-NonDiabetic
5.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.310400E-01
Normal-vs-NoPancreatitis
6.233000E-01
Pancreatitis-vs-NoPancreatitis
3.675400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.418000E-01
Normal-vs-N1
5.157000E-01
N0-vs-N1
9.597000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.437200E-01
Normal-vs-TP53-NonMutant
6.994600E-01
TP53-Mutant-vs-TP53-NonMutant
1.757380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
